RCF Q2 FY27: Consol PAT up 24% YoY to ₹131 Cr on chemicals surge, fertiliser profit dips
PAT +24.29% YoY · revenue -4.33% · margins expanding
₹5,063.19 Cr
-4.33% YoY
₹130.94 Cr
+24.29% YoY
2.57%
+0.6pp YoY
₹2.37
RCF's consolidated PAT for Q2 FY27 (quarter ended 30 September 2026) came in at ₹130.94 Cr, up 24.3% YoY from ₹105.35 Cr, even as consolidated revenue slipped 4.3% YoY to ₹5,063.19 Cr from ₹5,292.58 Cr. Standalone PAT was near-identical at ₹131.45 Cr (EPS ₹2.38 standalone / ₹2.37 consolidated), with the ₹0.51 Cr gap arising from the company's share of a joint-venture loss — the two bases tell the same story this quarter. Sequentially, revenue jumped 41.2% and PAT 78.1% over Q1 FY27 (₹3,585.71 Cr / ₹73.53 Cr), but that swing is a Kharif-season seasonality artifact for a urea-heavy fertiliser business rather than a sign of accelerating momentum — the YoY comparison is the one that matters here.
Q2 FY-2027 vs prior quarters
Net profit margin expanded to 2.59% from 1.99% YoY and operating margin to 5.97% from 4.05%, but the margin expansion masks a split performance across segments. The core Fertiliser segment — about 78% of revenue — saw its profit fall 21.7% YoY to ₹84.94 Cr from ₹108.49 Cr, even as fertiliser revenue grew 33.9% YoY to ₹3,945.22 Cr, because the Department of Fertilizers' revision of the energy norm for RCF's Thal unit (to 5.984 Gcal/MT from 6.200 Gcal/MT, retrospective to April 2025) cut subsidy income by a further ₹60.17 Cr this quarter — on top of ₹132.52 Cr booked for FY26 in Q1 FY27 and ₹39.02 Cr recognised for Q1 FY27 itself, taking the cumulative FY27 impact to ₹231.71 Cr. The quarter's profit growth instead came from Industrial Chemicals, whose segment profit nearly quadrupled to ₹144.93 Cr from ₹41.77 Cr YoY (+247%) on revenue growth of just 54.5% (₹505.93 Cr from ₹327.49 Cr) — implied segment margin expanded from roughly 12.8% to 28.6%, and its profit now exceeds Fertiliser's despite a fraction of the revenue. Trading, the third segment, collapsed 69.8% YoY to ₹608.40 Cr in revenue with profit falling to ₹10.57 Cr from ₹47.51 Cr, explaining most of the topline decline.
The stock went into the print at ₹108.1, up 2.9% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
No exceptional items in either this quarter or the year-ago quarter
We found no specific analyst or brokerage consensus estimates for RCF's Q2 FY27 PAT in public previews, so the print cannot be graded against the Street; the company also carries no formal prior guidance or concall outlook on record, so it cannot be graded against management's own targets either. During the quarter, RCF awarded a ₹797 Cr ammonia-plant revamp order to L&T (25 September 2026), shareholders approved a ₹1,500 Cr further public offer (26 September 2026), and the company onboarded Raju & Prasad as new statutory auditors — capacity and capital-raising moves that sit alongside, rather than explain, this quarter's P&L. No management press release accompanying this filing was available to cross-check against the reported numbers.
W1
Whether the Industrial Chemicals segment can sustain its ~28.6% margin (vs ~12.8% a year ago) that drove this quarter's profit growth
W2
Resolution of the ₹203.41 Cr cumulative GAIL gas-pooling dispute after DoF's October 2026 rejection of RCF's representation
W3
Trading segment revenue trajectory after the 69.8% YoY decline to ₹608.40 Cr
Informational and educational content only. Not investment advice.